Main > ONCOLOGY (**) > Skin Cancer>Melanoma>MET *** > Treatment > Co: USA. B. NivoluMAb ***



Co: USA. B. NivoluMAb ***'s subsections
(*) EU 2nd OK Date: 2018. 07.31.>
(*) USA 1st OK Date: 2014. 12.22.
(*) USA 2nd OK Date: 2017. 12.20.>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 10
Patent>UpDate: 2018. 10.16.
PD-1 Checkpoint Inhibitor
TradeMark
TradeMark Web-Site

Co: USA. B. NivoluMAb ***'s products
This section has no products